Institutional Ownership Zentalis Pharmaceuticals, Inc. (ZNTL)
This table provides information about the institutional ownership of Zentalis Pharmaceuticals, Inc. (ZNTL). We have compiled data on the 147 institutions that hold shares in the stock, with a total of 65.3 Million shares, which have been reported (via 13F filing form) to have a value of $161 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Matrix Capital Management Company, LP
Waltham, MA |
Feb 13, 2025 Q4 2024 |
13,959,973
shares
|
$32.4 Million
2.05% of portfolio
|
Q2 2023
Added 51.74%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
4,818,546
shares
|
$11.2 Million
0.0% of portfolio
|
Q2 2024
Added 3.72%
|
|
|
Eventide Asset Management, LLC
Boston, MA |
Feb 14, 2025 Q4 2024 |
4,475,054
shares
|
$10.4 Million
0.26% of portfolio
|
Q4 2024
Reduced 47.65%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
3,271,240
shares
|
$7.59 Million
0.0% of portfolio
|
Q4 2024
Reduced 29.08%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
3,216,727
shares
|
$7.46 Million
0.0% of portfolio
|
Q4 2024
Added 18.37%
|
|
|
Decheng Capital LLC
Menlo Park, CA |
Feb 14, 2025 Q4 2024 |
2,338,095
shares
|
$5.42 Million
1.52% of portfolio
|
Q4 2024
Reduced 24.77%
|
|
|
Decheng Capital Management Iii (Cayman), LLC
|
Nov 13, 2023 Q3 2023 |
2,099,583
shares
|
$4.87 Million
23.31% of portfolio
|
Q2 2023
Added 15.07%
|
|
|
Opaleye Management Inc.
Boston, MA |
Feb 14, 2025 Q4 2024 |
1,767,500
shares
|
$4.1 Million
1.05% of portfolio
|
Q4 2024
Added 82.78%
|
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
1,713,188
shares
|
$3.97 Million
0.0% of portfolio
|
Q4 2024
Added 6.31%
|
|
|
Almitas Capital LLC
Santa Monica, CA |
Feb 14, 2025 Q4 2024 |
1,626,896
shares
|
$3.77 Million
2.4% of portfolio
|
Q4 2024
Added 69.3%
|
|
|
Primecap Management CO
Pasadena, CA |
Feb 10, 2025 Q4 2024 |
1,520,630
shares
|
$3.53 Million
0.0% of portfolio
|
Q4 2024
Added 1.51%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
1,312,964
shares
|
$3.05 Million
0.0% of portfolio
|
Q4 2024
Added 1.61%
|
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
1,288,985
shares
|
$2.99 Million
0.0% of portfolio
|
Q4 2024
Added 3.4%
|
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Feb 14, 2025 Q4 2024 |
1,239,459
shares
|
$2.88 Million
0.0% of portfolio
|
Q4 2024
Added 9.82%
|
|
|
Verition Fund Management LLC
Greenwich, CT |
Feb 14, 2025 Q4 2024 |
1,217,094
shares
|
$2.82 Million
0.02% of portfolio
|
Q4 2024
Reduced 19.09%
|
|
|
Bio Impact Capital LLC
Cambridge, MA |
Feb 14, 2025 Q4 2024 |
1,106,851
shares
|
$2.57 Million
0.5% of portfolio
|
Q4 2024
Reduced 24.49%
|
|
|
Acadian Asset Management LLC
Boston, MA |
Feb 11, 2025 Q4 2024 |
1,067,233
shares
|
$2.48 Million
0.01% of portfolio
|
Q4 2024
Added 305.46%
|
|
|
Integral Health Asset Management, LLC
|
Feb 14, 2025 Q4 2024 |
1,050,000
shares
|
$2.44 Million
0.28% of portfolio
|
Q4 2024
New holding
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
979,855
shares
|
$2.27 Million
0.0% of portfolio
|
Q4 2024
Reduced 5.5%
|
|
|
Tybourne Capital Management (Hk) LTD
Hong Kong, K3 |
Feb 14, 2025 Q4 2024 |
961,486
shares
|
$2.23 Million
0.92% of portfolio
|
Q2 2023
Reduced 41.1%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Feb 14, 2025 Q4 2024 |
957,563
shares
|
$2.22 Million
0.0% of portfolio
|
Q4 2024
Added 8.07%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
918,107
shares
|
$2.13 Million
0.0% of portfolio
|
Q4 2024
Added 44.8%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Feb 14, 2025 Q4 2024 |
889,700
shares
|
$2.06 Million
0.01% of portfolio
|
Q4 2024
Reduced 22.59%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Feb 12, 2025 Q4 2024 |
859,710
shares
|
$1.99 Million
0.0% of portfolio
|
Q4 2024
Added 75.74%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
641,407
shares
|
$1.49 Million
0.0% of portfolio
|
Q4 2024
Added 35.22%
|